Aitken Klee

What Aitken Klee does

Aitken Klee LLP is a Canadian boutique law firm founded in 2013 and headquartered in Ottawa, Ontario (180 Elgin Street, Suite 1400), with a second office in Toronto added in 2014. The firm specializes exclusively in complex intellectual property litigation — patent, trademark, and copyright disputes at all court levels including the Supreme Court of Canada — and positions itself around taking on difficult matters, including appeals of cases previously lost by other counsel. Its headcount sits in the 11-50 employee range, organized around a team of more than a dozen seasoned IP litigators that includes named partners David Aitken and Marcus Klee (whose 2012 SCC win setting aside Pfizer's Viagra patent is the firm's foundational case) and 2014 lateral additions Jonathan Stainsby, Bill Mayo, and Lesley Caswell.

The firm's service lines are vertically organized: pharmaceutical patent litigation under the Patent Act and the Patented Medicines (Notice of Compliance) Regulations is the dominant practice, supplemented by biopharmaceutical IP (including Canada's first biosimilar patent litigation), natural resources IP (oil sands, drilling technology), IT/software/communications IP, medical device IP, CIPO proceedings, Access to Information matters, appellate/intervention work, and a newer Influencer Law practice for content creators. The named client roster is concentrated in pharmaceuticals (Teva Canada, Pharmascience, Dr. Reddy's, Laboratoire Riva, Taro, Natco Canada, CGPA, Pfizer) with secondary exposure to energy (Suncor), medical devices (W.L. Gore), technology (Two-Way Media), consumer goods (Unilever Canada), entertainment (Warner Brothers), and education (AUCC, ACCC). Documented client outcomes include well over $175 million in Teva damages awards (olanzapine and venlafaxine), a $500 million NAFTA arbitration claim involving Eli Lilly, and judgments described as 'hundreds of millions of dollars in damages' across pharmaceutical mandates.

Commercially, Aitken Klee operates as a partner-led Limited Liability Partnership on a professional services model, generating revenue through legal fees that are quote-based and not publicly disclosed. The firm has no external funding, parent company, or institutional ownership, and pursues no productized technology offering. Business development is driven entirely by reputation, landmark case outcomes, sustained analyst rankings (IAM Tier 1, Chambers, Lexpert, MIP, Legal 500, Leaders League, Benchmark, Canadian Lawyer, Best Lawyers in Canada), conference participation, and thought leadership via an active blog covering biosimilar guidance, FCA decisions, PMPRB guidelines, and trademark/copyright developments.

Name

Aitken Klee

Legal name

Aitken Klee LLP

Website

https://aitkenklee.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Aitken Klee LLP is a Canadian boutique law firm (Ottawa HQ, founded 2013) specializing in complex intellectual property litigation — primarily patent disputes for pharmaceutical manufacturers under the Patent Act and PMNOC Regulations — at all court levels including the Supreme Court of Canada.

Ownership category

akta.pro rank

Product category

Intellectual Property Litigation Services

NAICS

Offices of Lawyers (541110)

SIC

Services-Legal Services (8111)

akta.pro primary industry

IP Compliance, Anti-Counterfeiting & Enforcement (BPAHAMAK)

akta.pro secondary industries

Copyright Services & Content Protection (BPAHAMAC), eDiscovery, Litigation Support & Legal Hold (BPAEAPAE)

Keywords

• Intellectual property litigation
• Patent litigation services
• Pharmaceutical patent law
• Trademark litigation
• Copyright litigation

Headquarters

HQ city

Ottawa

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Legal Services Revenue: The firm generates revenue through legal fees for IP litigation services including patent, trademark, and copyright cases at all court levels.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Aitken Klee is a Canadian intellectual property litigation boutique law firm that represents enterprise clients in patent, trademark, and copyright disputes at all court levels, including the Supreme Court of Canada. The firm specializes in pharmaceutical patent litigation under the Patent Act and Patented Medicines (Notice of Compliance) Regulations, biopharmaceutical patent matters, and complex multi-jurisdictional IP disputes, delivering its services through direct legal representation, courtroom advocacy, and appellate interventions.

Product overview

Aitken Klee is a Canadian intellectual property litigation law firm offering comprehensive legal services rather than a technology product platform. The firm's core offering consists of IP litigation services spanning patent, trademark, and copyright disputes at all court levels including the Supreme Court of Canada. The main service lines include pharmaceutical patent litigation, biopharmaceutical services, natural resources IP, IT/software IP, medical device IP, CIPO proceedings, Access to Information matters, appeals and interventions, and influencer law services.

Differentiator

Problem solved

Functional benefit

Products and services

• Intellectual Property Litigation Full-service IP litigation including patent, trademark, and copyright disputes at all court levels, with extensive trial experience, for enterprise clients.
• Pharmaceutical Patent Litigation Specialized representation of pharmaceutical manufacturers in patent litigation under the Patent Act and Patented Medicines (Notice of Compliance) Regulations, covering compound, formulation, and use patents.
• Biopharmaceutical IP Litigation Legal counsel for biopharmaceutical products including recombinant protein IP disputes, leveraging lawyers with advanced life sciences degrees; includes the first biosimilar patent litigation in Canada.
• Natural Resources IP Litigation Patent litigation in the natural resources sector covering hard rock directional drilling, pipe heating cable for mining, coiled tubing injector systems, drilling fluid recovery, and oil sands tailings remediation technology.
• IT, Software and Communications IP Enforcement and defense of intellectual property disputes in IT, software, and communications sectors, including internet streaming technology cases.
• Medical Device IP Litigation Representation of medical device companies from multinational corporations to startups in patent infringement and validity cases, including artificial artery and other biomedical device matters.
• Canadian Intellectual Property Office (CIPO) Proceedings Representation in CIPO proceedings including re-examinations, protests, and due care responses.
• Access to Information (ATI) Representation Representation of clients in Access to Information responses and requests.
• Appeals and Interventions Appellate advocacy including stepping in on difficult cases initially handled by other firms, strategic advice, and Supreme Court of Canada interventions.
• Influencer Law Legal services for content creators and UGC creators including brand deals, collaboration agreements, copyright, trademark, privacy, and defamation matters.

Quantifiable outcome

• Obtained Supreme Court of Canada decision invalidating Pfizer's Viagra patent (2012 SCC 60)
• +4 more outcomes

Named customers15 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Marks & Clerk Canada: Canadian arm of the global IP firm Marks & Clerk. Overlaps with Aitken Klee in Canadian IP litigation and patent strategy, with particular strength in life sciences and engineering disciplines similar to Aitken Klee's pharmaceutical bench.
• Bereskin & Parr LLP: Leading Canadian IP boutique with strong patent and trademark litigation practices. Competes head-to-head with Aitken Klee in Canadian IP disputes, particularly in pharmaceutical and technology sectors, and shares the boutique positioning that differentiates both from full-service firms.
• Smart & Biggar: Canada's largest and most prominent IP firm, with deep patent prosecution and litigation benches across Ottawa, Toronto, Montreal, and Vancouver. Directly comparable to Aitken Klee in Canadian IP litigation and pharmaceutical patent work, though Smart & Biggar is significantly larger and includes prosecution services.
• Robic LLP: Quebec-based IP boutique with a national litigation practice. Comparable as a Canadian IP-focused firm handling patent, trademark, and copyright litigation, though it also offers prosecution and is anchored in Montreal rather than Toronto/Ottawa.

Broad incumbents

• Fasken Martineau DuMoulin LLP: Major Canadian full-service firm with a respected IP litigation practice. Competes with Aitken Klee for IP mandates, particularly in technology and life sciences, and offers the breadth of a national full-service platform.
• McCarthy Tétrault LLP: One of Canada's largest full-service firms with a substantial IP litigation group. Competes for the same enterprise pharmaceutical and technology IP mandates as Aitken Klee, with a much larger national and international footprint.
• Osler, Hoskin & Harcourt LLP: Prominent Canadian full-service firm with a top-tier IP litigation practice. Frequently appears opposite or alongside Aitken Klee in major pharmaceutical patent matters, but its broader corporate and transactional platform is a structural difference.
• Norton Rose Fulbright Canada: Global full-service firm with a strong Canadian IP litigation practice. Overlaps with Aitken Klee on cross-border patent disputes and is particularly relevant for international pharma clients needing coordinated multi-jurisdictional representation.
• Gowling WLG (Canada): Major international full-service firm with one of Canada's leading IP litigation groups. Competes with Aitken Klee on patent and trademark litigation, but offers a much broader platform (corporate, regulatory, litigation outside IP) that appeals to enterprise clients seeking one-stop service.

Emerging players

• Heer Law: Toronto-based IP boutique with a focus on patent and trademark litigation. Comparable in boutique positioning to Aitken Klee, though smaller in scale and less concentrated on pharmaceutical patent work, making it a partial-overlap emerging peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aitken-klee

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aitken Klee